Press release to announce that ….
To register:
https://zoom.us/webinar/register/WM
Weavegen and Oncimmune signs distribution agreement detail here
https://janesisbioscience.com/wp-content/uploads/2017/11/170531_Oncimmune-Kit-CE-Mark_FINAL.pdf
https://news.sky.com/story/ground-breaking-blood-test-could-reduce-lung-cancer-deaths-11805344 Source: Sky News 9 September 2019
Oncimmune Holdings plc (AIM:ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces it has acquired Protagen Diagnostics AG (“Protagen”) for a total consideration of up to £4.11 million
Singapore General Hospital on 7 March 2018 by invitation only
https://www.straitstimes.com/singapore/health/cgh-found-guilty-of-negligence-in-cancer-diagnosis
Janesis Bioscience is pleased to announce that Oncimmune Early CDT-Lung Test Kit is now approved by the Singapore Health Sciences Authority for in-vitro diagnostics